Teladoc Reports $13.7B Loss for 2022, Just Two Years after Livongo Acquisition

Mar 20, 2023 | Laboratory Mergers and Acquisitions, Laboratory News, Laboratory Resources, Laboratory Sales and Marketing, Laboratory Testing, Precision Medicine

Loss could indicate an industrywide slowdown in digital health adoption and suggests medical laboratories will want to continue developing a virtual care strategy Only two years after Teladoc Health (NYSE:TDOC) completed acquisition of Livongo, a data-based health coaching company, the virtual healthcare provider reported a 2022 net loss of $13.7 billion, a company press release announced. The loss, which has been described as “historic,” is “mostly from a write-off related to the plummeting...

Teladoc Health’s Agreement to Acquire Livongo Is a Blockbuster Deal in the Telehealth Sector, But Is it Positive or Negative for Clinical Laboratories?

Oct 9, 2020 | International Laboratory News, International Laboratory News, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing, Management & Operations

Physician acceptance of virtual visits with their patients is being accelerated by the pandemic and the pending merger would combine the nation’s two biggest telehealth companies Telehealth visits with virtual healthcare providers are increasing as the COVID-19 pandemic continues. This is forcing the entire healthcare industry—clinical laboratories in particular—to adapt to new methods of patient data exchange and communications. What is not clear is how independent clinical laboratories and...
;